Sanofi Price to Free Cash Flow Ratio 2006-2019 | SNY

Historical price to free cash flow ratio values for Sanofi (SNY) since 2006.
Sanofi Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2019-09-20 46.46 17.48
2019-03-31 44.28 $2.66 16.66
2018-03-31 38.26 $3.53 10.83
2017-12-31 41.05 $3.53 11.62
2017-09-30 47.53 $3.42 13.90
2017-06-30 45.73 $3.42 13.37
2017-03-31 41.78 $3.19 13.11
2016-12-31 37.34 $3.19 11.72
2016-09-30 35.26 $0.64 55.13
2016-06-30 38.64 $1.72 22.40
2016-03-31 35.56 $2.17 16.40
2015-09-30 42.04 $2.95 14.27
2015-06-30 43.86 $4.71 9.31
2014-06-30 45.60 $3.63 12.58
2013-06-30 42.64 $6.68 6.39
2012-06-30 30.22 $5.90 5.12
2012-03-31 29.61 $5.88 5.03
2011-12-31 27.93 $5.88 4.75
2011-09-30 25.07 $5.98 4.19
2011-06-30 30.70 $5.98 5.13
2011-03-31 26.02 $5.97 4.36
2010-12-31 23.81 $5.97 3.99
2010-09-30 24.56 $5.38 4.57
2010-06-30 22.20 $5.38 4.13
2010-03-31 26.62 $5.50 4.84
2009-12-31 27.98 $5.50 5.08
2009-09-30 26.33 $6.18 4.26
2009-06-30 21.01 $6.18 3.40
2009-03-31 18.86 $5.83 3.23
2008-12-31 21.72 $5.83 3.72
2008-09-30 22.20 $4.51 4.92
2008-06-30 22.44 $4.51 4.98
2008-03-31 24.28 $4.31 5.63
2007-12-31 29.45 $4.31 6.83
2007-09-30 27.44 $4.27 6.43
2007-06-30 26.05 $4.27 6.11
2007-03-31 27.46 $4.60 5.97
2006-12-31 29.14 $4.60 6.34
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $111.209B $40.701B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.174B 14.99
Roche Holding AG (RHHBY) Switzerland $241.683B 0.00
Merck (MRK) United States $212.562B 17.48
Pfizer (PFE) United States $201.220B 11.85
Novartis AG (NVS) Switzerland $197.737B 17.02
Novo Nordisk (NVO) Denmark $120.697B 21.33
AstraZeneca (AZN) United Kingdom $114.317B 22.12
Eli Lilly (LLY) United States $108.824B 20.31
AbbVie (ABBV) United States $105.372B 8.44
GlaxoSmithKline (GSK) United Kingdom $102.412B 12.87
Bristol-Myers Squibb (BMY) United States $81.559B 11.57
Bayer (BAYRY) Germany $68.561B 9.99
H Lundbeck (HLUYY) Denmark $6.721B 9.70